Cargando…

Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations

We report generation of induced pluripotent stem cell (iPSC) lines from ten Parkinson’s disease (PD) patients carrying SNCA, PARK2, LRRK2, and GBA mutations, and one age-matched control. After validation of pluripotency, long-term genome stability, and integration-free reprogramming, eight of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Momcilovic, Olga, Sivapatham, Renuka, Oron, Tal Ronnen, Meyer, Morten, Mooney, Sean, Rao, Mahendra S., Zeng, Xianmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871453/ https://www.ncbi.nlm.nih.gov/pubmed/27191603 http://dx.doi.org/10.1371/journal.pone.0154890

Ejemplares similares

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
por: Shaltouki, Atossa, et al.
Publicado: (2015)

Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
por: Nuytemans, Karen, et al.
Publicado: (2010)

A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021)

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?
por: Roopnarain, Karisha, et al.
Publicado: (2023)

Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2
por: Bras, Jose, et al.
Publicado: (2008)

Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population
por: Yu, Wen-Juan, et al.
Publicado: (2015)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
por: Smith, Laura J., et al.
Publicado: (2022)

Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
por: Volta, Mattia
Publicado: (2022)

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2016)

Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin
por: Nuytemans, Karen, et al.
Publicado: (2020)

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
por: Droby, Amgad, et al.
Publicado: (2022)

Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population
por: Fang, Jie, et al.
Publicado: (2016)

Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease
por: Vetchinova, Anna S., et al.
Publicado: (2023)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

Alpha‐synuclein dynamics in induced pluripotent stem cell‐derived dopaminergic neurons from a Parkinson’s disease patient (PARK4) with SNCA triplication
por: Fukusumi, Hayato, et al.
Publicado: (2021)

Mutations in GBA, SNCA, and VPS35 are not associated with Alzheimer’s disease in a Chinese population: a case-control study
por: Wen, Ya-Fei, et al.
Publicado: (2021)

A platform for rapid generation of single and multiplexed reporters in human iPSC lines
por: Pei, Ying, et al.
Publicado: (2015)

Who is at Risk of Parkinson Disease? Refining the Preclinical Phase of GBA1 and LRRK2 Variant Carriers: a Clinical, Biochemical, and Imaging Approach
por: Menozzi, Elisa, et al.
Publicado: (2023)

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
por: Merchant, Kalpana M., et al.
Publicado: (2023)

SNCA-AS1 in aging and Parkinson’s disease
por: Carelli, Stephana, et al.
Publicado: (2022)

The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation
por: Iakovenko, E. V., et al.
Publicado: (2020)

In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation
por: Chang, Kuo-Hsuan, et al.
Publicado: (2021)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease
por: Weykopf, Beatrice, et al.
Publicado: (2019)

LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons
por: Sanyal, Anwesha, et al.
Publicado: (2020)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
por: Labrador-Garrido, Adahir, et al.
Publicado: (2023)

Cohesin controls intestinal stem cell identity by maintaining association of Escargot with target promoters
por: Khaminets, Aliaksandr, et al.
Publicado: (2020)

Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line
por: Ruz, Clara, et al.
Publicado: (2022)

The Frequency of Korean Patients With Parkinson’s Disease Carrying GBA Mutations in a Subgroup With Age at Onset ≤ 55 Years Old
por: Hwangbo, Jin, et al.
Publicado: (2023)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease
por: Marrone, Lara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6802nkjlh1dlk1e9731dafh3iv